New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure.
<h4>Background</h4>Growing evidence exists for soluble Angiotensin Converting Enzyme-2 (sACE2) as a biomarker in definitive heart failure (HF), but there is little information about changes in sACE2 activity in hypertension with imminent heart failure and in reverse remodeling.<h4>...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0087845&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849720427595694080 |
|---|---|
| author | Katalin Úri Miklós Fagyas Ivetta Mányiné Siket Attila Kertész Zoltán Csanádi Gábor Sándorfi Marcell Clemens Roland Fedor Zoltán Papp István Édes Attila Tóth Erzsébet Lizanecz |
| author_facet | Katalin Úri Miklós Fagyas Ivetta Mányiné Siket Attila Kertész Zoltán Csanádi Gábor Sándorfi Marcell Clemens Roland Fedor Zoltán Papp István Édes Attila Tóth Erzsébet Lizanecz |
| author_sort | Katalin Úri |
| collection | DOAJ |
| description | <h4>Background</h4>Growing evidence exists for soluble Angiotensin Converting Enzyme-2 (sACE2) as a biomarker in definitive heart failure (HF), but there is little information about changes in sACE2 activity in hypertension with imminent heart failure and in reverse remodeling.<h4>Methods, findings</h4>Patients with systolic HF (NYHAII-IV, enrolled for cardiac resynchronisation therapy, CRT, n = 100) were compared to hypertensive patients (n = 239) and to a healthy cohort (n = 45) with preserved ejection fraction (EF>50%) in a single center prospective clinical study. The status of the heart failure patients were checked before and after CRT. Biochemical (ACE and sACE2 activity, ACE concentration) and echocardiographic parameters (EF, left ventricular end-diastolic (EDD) and end-systolic diameter (ESD) and dP/dt) were measured. sACE2 activity negatively correlated with EF and positively with ESD and EDD in all patient's populations, while it was independent in the healthy cohort. sACE2 activity was already increased in the hypertensive group, where signs for imminent heart failure (slightly decreased EF and barely increased NT-proBNP levels) were detected. sACE2 activities further increased in patients with definitive heart failure (EF<50%), while sACE2 activities decreased with the improvement of the heart failure after CRT (reverse remodeling). Serum angiotensin converting enzyme (ACE) concentrations were lower in the diseased populations, but did not show a strong correlation with the echocardiographic parameters.<h4>Conclusions</h4>Soluble ACE2 activity appears to be biomarker in heart failure, and in hypertension, where heart failure may be imminent. Our data suggest that sACE2 is involved in the pathomechanism of hypertension and HF. |
| format | Article |
| id | doaj-art-c6f51f9c13ce4d29b7eb4a6aeafb6df3 |
| institution | DOAJ |
| issn | 1932-6203 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-c6f51f9c13ce4d29b7eb4a6aeafb6df32025-08-20T03:11:55ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0194e8784510.1371/journal.pone.0087845New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure.Katalin ÚriMiklós FagyasIvetta Mányiné SiketAttila KertészZoltán CsanádiGábor SándorfiMarcell ClemensRoland FedorZoltán PappIstván ÉdesAttila TóthErzsébet Lizanecz<h4>Background</h4>Growing evidence exists for soluble Angiotensin Converting Enzyme-2 (sACE2) as a biomarker in definitive heart failure (HF), but there is little information about changes in sACE2 activity in hypertension with imminent heart failure and in reverse remodeling.<h4>Methods, findings</h4>Patients with systolic HF (NYHAII-IV, enrolled for cardiac resynchronisation therapy, CRT, n = 100) were compared to hypertensive patients (n = 239) and to a healthy cohort (n = 45) with preserved ejection fraction (EF>50%) in a single center prospective clinical study. The status of the heart failure patients were checked before and after CRT. Biochemical (ACE and sACE2 activity, ACE concentration) and echocardiographic parameters (EF, left ventricular end-diastolic (EDD) and end-systolic diameter (ESD) and dP/dt) were measured. sACE2 activity negatively correlated with EF and positively with ESD and EDD in all patient's populations, while it was independent in the healthy cohort. sACE2 activity was already increased in the hypertensive group, where signs for imminent heart failure (slightly decreased EF and barely increased NT-proBNP levels) were detected. sACE2 activities further increased in patients with definitive heart failure (EF<50%), while sACE2 activities decreased with the improvement of the heart failure after CRT (reverse remodeling). Serum angiotensin converting enzyme (ACE) concentrations were lower in the diseased populations, but did not show a strong correlation with the echocardiographic parameters.<h4>Conclusions</h4>Soluble ACE2 activity appears to be biomarker in heart failure, and in hypertension, where heart failure may be imminent. Our data suggest that sACE2 is involved in the pathomechanism of hypertension and HF.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0087845&type=printable |
| spellingShingle | Katalin Úri Miklós Fagyas Ivetta Mányiné Siket Attila Kertész Zoltán Csanádi Gábor Sándorfi Marcell Clemens Roland Fedor Zoltán Papp István Édes Attila Tóth Erzsébet Lizanecz New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure. PLoS ONE |
| title | New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure. |
| title_full | New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure. |
| title_fullStr | New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure. |
| title_full_unstemmed | New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure. |
| title_short | New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure. |
| title_sort | new perspectives in the renin angiotensin aldosterone system raas iv circulating ace2 as a biomarker of systolic dysfunction in human hypertension and heart failure |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0087845&type=printable |
| work_keys_str_mv | AT katalinuri newperspectivesinthereninangiotensinaldosteronesystemraasivcirculatingace2asabiomarkerofsystolicdysfunctioninhumanhypertensionandheartfailure AT miklosfagyas newperspectivesinthereninangiotensinaldosteronesystemraasivcirculatingace2asabiomarkerofsystolicdysfunctioninhumanhypertensionandheartfailure AT ivettamanyinesiket newperspectivesinthereninangiotensinaldosteronesystemraasivcirculatingace2asabiomarkerofsystolicdysfunctioninhumanhypertensionandheartfailure AT attilakertesz newperspectivesinthereninangiotensinaldosteronesystemraasivcirculatingace2asabiomarkerofsystolicdysfunctioninhumanhypertensionandheartfailure AT zoltancsanadi newperspectivesinthereninangiotensinaldosteronesystemraasivcirculatingace2asabiomarkerofsystolicdysfunctioninhumanhypertensionandheartfailure AT gaborsandorfi newperspectivesinthereninangiotensinaldosteronesystemraasivcirculatingace2asabiomarkerofsystolicdysfunctioninhumanhypertensionandheartfailure AT marcellclemens newperspectivesinthereninangiotensinaldosteronesystemraasivcirculatingace2asabiomarkerofsystolicdysfunctioninhumanhypertensionandheartfailure AT rolandfedor newperspectivesinthereninangiotensinaldosteronesystemraasivcirculatingace2asabiomarkerofsystolicdysfunctioninhumanhypertensionandheartfailure AT zoltanpapp newperspectivesinthereninangiotensinaldosteronesystemraasivcirculatingace2asabiomarkerofsystolicdysfunctioninhumanhypertensionandheartfailure AT istvanedes newperspectivesinthereninangiotensinaldosteronesystemraasivcirculatingace2asabiomarkerofsystolicdysfunctioninhumanhypertensionandheartfailure AT attilatoth newperspectivesinthereninangiotensinaldosteronesystemraasivcirculatingace2asabiomarkerofsystolicdysfunctioninhumanhypertensionandheartfailure AT erzsebetlizanecz newperspectivesinthereninangiotensinaldosteronesystemraasivcirculatingace2asabiomarkerofsystolicdysfunctioninhumanhypertensionandheartfailure |